Determinants of lung disease progression measured by lung clearance index in children with cystic fibrosis
Sanja Stanojevic(Dalhousie University), Félix Ratjen(Hospital for Sick Children), Sylvia Jara(Riley Hospital for Children), Michelle Shaw(SickKids Foundation), Hartmut Grasemann(Hospital for Sick Children), Charles Clem(Riley Hospital for Children), Nancy McDonald(Lucile Packard Children's Hospital), Lisa France(University of North Carolina at Chapel Hill), Stephanie D. Davis(University of North Carolina at Chapel Hill), Lucy Perrem(Children's Health Ireland at Crumlin), Melinda Solomon(Hospital for Sick Children), Neil Sweezey(Hospital for Sick Children), Renée Jensen(University of North Carolina at Chapel Hill), Sarah Isaac(Hospital for Sick Children), Miriam Davis(Riley Hospital for Children), Julia Guido(SickKids Foundation), George Retsch‐Bogart(University of North Carolina at Chapel Hill), Valerie Waters(University of Toronto), Don B. Sanders(Indiana University School of Medicine)
Cited by 27
Related Papers
Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del<i>CFTR</i>
|New England Journal of Medicine|2015|1.6k
The Effect of Chronic Infection With Aspergillus fumigatus on Lung Function and Hospitalization in Patients With Cystic Fibrosis
|CHEST Journal|2009|372
Mutations in <i>RSPH1</i> Cause Primary Ciliary Dyskinesia with a Unique Clinical and Ciliary Phenotype
|American Journal of Respiratory and Critical Care Medicine|2014|229
Zebrafish Ciliopathy Screen Plus Human Mutational Analysis Identifies C21orf59 and CCDC65 Defects as Causing Primary Ciliary Dyskinesia
|The American Journal of Human Genetics|2013|201
Mutations in SPAG1 Cause Primary Ciliary Dyskinesia Associated with Defective Outer and Inner Dynein Arms
|The American Journal of Human Genetics|2013|145